Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page
- Check4 days agoChange DetectedA minor revision update was applied: v3.4.1 was added and v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedShow glossary feature added to the page, along with minor capitalization changes (Last Update Submitted that Met QC Criteria, No FEAR Act Data) and a revision label updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 at the bottom of the page. No study content or user-facing functionality was changed.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter/versioning notes were updated: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page no longer displays the site-wide government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.